Looking to gain an advantageous foothold in the burgeoning medical marijuana market, India Globalization Capital, Inc. (NYSE MKT: IGC) is developing innovative cannabis-based combination therapies that have application for both humans and animals. The company’s focus is on treating pain, post-traumatic stress disorder (PTSD), chronic and terminal neurological and oncological diagnoses, cachexia, and other life-altering medical conditions.

IGC continues developing a portfolio of patent filings for phytocannabinoid-based treatments and has filed six patents to date. The company currently has three products in pre-clinical trials: IGC-501 for treatment of neuropathic pain in adult humans, IGC-502 for treatment of seizures in animals, and IGC-504 for treatment of cachexia in humans and animals.

Two of IGC’s patent filings, IGC-502 and IGC-505, are for combination therapies to treat seizures in dogs and cats, which represents a remarkably large market. Statistics show that between one percent and over five percent of dogs in the United States have some kind of seizure disorder. Certain dog breeds with hereditary epilepsy may have up to 15-20 percent incidence of seizures.

IGC’s novel therapy uses cannabinoid extracts in combination with other drugs to treat seizures in both dogs and cats, and this therapy has potential for application in humans, as well. The therapy can be administered through a variety of delivery technologies.

Operating on the belief that expanding cannabis legalization will create explosive demand for cannabinoid-based pharmaceutical therapies and related technologies and services, IGC is racing to be at the head of the pack and to be a first mover in the marijuana space by developing novel therapies, filing patent applications, and acquiring technologies from related industries that can cross over to cannabis as soon as permitted by federal law.

The company largely employs an outsourced model and has formed strategic alliances with doctors and scientists with expertise in central and peripheral nervous system disorders, the FDA process, and in pharmaceutical, nutraceutical and veterinarian trials. IGC also continues seeking information exchanges with medical cannabis dispensaries, doctors, research scientists, biotech companies, and medical and business professionals within the cannabinoid space, placing great value on collaborative research that can aid in the commercialization of products and in locating new ways to help patients — both human and animal — benefit from cannabinoids.

For more information, visit the company’s website at www.IGCinc.us

Let us hear your thoughts: India Globalization Capital, Inc. Message Board

Slowly but surely cannabis is losing the stigma that has plagued it for close to one hundred years. Even some who frown on its use for recreational purposes are willing to consider that there may be therapeutic benefits in extracts of the cannabis sativa plant and so, increasingly, cannabinoids are being investigated to determine their effectiveness to treat a variety of debilitating medical conditions. Cannabinoid pharma is emerging as an entirely new industry segment in pharmaceuticals, and, as it does so, one innovative research company is blazing a trail in this new market by creating a niche of its own. India Globalization Capital, Inc. (NYSE MKT: IGC) has created its own space in pharmaceuticals. The Bethesda, Maryland-based company is a first mover in “combination therapies” that merge cannabinoids with existing drugs to provide more effective remedies.

IGC is not only a first mover in combination therapies; the company is also a fast mover. To date, IGC has dispatched six provisional patent filings to the U.S. Patent and Trademark Office for the indications of pain, medical refractory epilepsy, seizures, cachexia and eating disorders. Together, the remedies for these conditions present huge market opportunity, and IGC’s current low valuation versus comparable cannabis companies represents an important alert for all investors in this burgeoning industry.

IGC-501 is being developed to combat pain. The pain market represents a significant component of the health care system, with The Journal of Pain reporting in September 2012 that the annual estimated national cost of pain ranges from $560 billion to $635 billion, a figure that exceeds the cost of treating all other priority health conditions. Also, a NetworkNewsWire report on data released by Transparency Market Research estimates the global pain management therapeutics market will have a 3.7 percent CAGR through 2024, to reach $83.0 billion (http://dtn.fm/cMh1z).

Chronic pain takes such an exacting toll on the nation’s health that the American Pain Society has recommended pain be characterized as a fifth ‘vital sign’, along with body temperature, pulse rate, respiratory rate and blood pressure. Pain treatment can save lives. Terminal illnesses are often accompanied by levels of pain so intense and difficult to treat that death seems preferable. In addition, arthritis has been particularly problematic for women, according to the Arthritis Foundation, which reports that since 1999 there has been a 22 percent increase in the number of women who attribute their disability to arthritis.

As awareness of the effects of chronic pain has grown, increasingly powerful drugs such as morphine, codeine, and hydrocodone are being prescribed. However, these opioids are treacherously addictive and their use is often subverted from pain relief, making their way into recreational use. According to the Centers for Disease Control (CDC), 29,000 Americans die every year from opioid-related overdoses. This alarming statistic shows the pressing need for less addictive analgesics like IGC-501.

IGC-503 tackles refractory epilepsy, which affects about 50 million in the U.S. alone. Refractory epilepsy refers to cases of epilepsy that are unresponsive to current medications. Also in the pipeline is IGC-504, intended for those who suffer from cachexia, known as wasting syndrome. About 1.3 million in the U.S. experience cachexia associated with cancer, multiple sclerosis (MS), Parkinson’s, HIV/AIDS and other devastating maladies. In addition, there is IGC-506, designed to combat eating disorders, which are said to affect about 30 million Americans (http://dtn.fm/2j6Pq). Two other patents, IGC-502 and IGC-505, are designed to treat epileptic seizures in dogs and cats.

On the release of its financial results for the third-quarter ended December 31, 2016, CEO Ram Mukunda stated, “In 2017, our goal is to accelerate the development of our cannabis-based therapy portfolio to support key indications such as pain, seizures, cachexia, PTSD, and depression. In tandem, we expect to initiate pre-clinical trials on IGC-501-pain, IGC-502-seizures and IGC-504-cachexia.”

For more information, visit the company’s website at www.IGCinc.us

Let us hear your thoughts: India Globalization Capital, Inc. Message Board

Net Element, Inc. (NASDAQ: NETE), for the three months ended March 31, 2017, enjoyed over 20% growth in revenues to $13,561,941, versus $11,261,059 for the same period a year earlier. North America Transaction Solutions, one of three operating segments of the global financial company, drove the firm’s growth, generating 81% of total sales compared to 70% during the same period of the prior year.

Net Element is a financial technology group that processes global transactions in an omni-channel environment in what is becoming a world of cashless transaction processing. The company processes electronic payments from point-of-sale and mobile devices.

Net revenues for the company were generated principally by payment processing fees in North America, where transactions jumped 40%, exhibiting organic growth, according to Zacks SCR Digest (http://nnw.fm/mTJ49). In 2016, Net Element recorded a 54% jump in North America to $42.1 million. That accounted for about 78% of total company sales for the year.

In the first quarter of 2017, North American Transactions increased their dominance of company sales — contributing 81% of Net Element sales. At the same time, the North American segment maintained its gross margin performance — contributing 14% for the first quarter of 2017 versus 15% during the same period of the prior year.

As the North American segment was cementing its hold on company revenues, mobile solutions continued their decline. In the first quarter of 2016, mobile solutions contributed 18% of company sales; that number fell to just 6% in the first quarter of 2017. Its sales dropped from $1,993,504 in 2016 down to $856,993 in the first quarter of 2017.

As a result of that performance, Oleg Firer, CEO of Net Element, said in a news release, “We are undertaking several strategic changes in the mobile solutions segment, which should yield results in the third-quarter of this year.”

SeeThruEquity, in an April 12, 2017, updated research report (http://nnw.fm/fFPV7), projects the company’s sales in FY 2017 at $62.9 million.

For more information, refer to www.NetElement.com

Although one of a number of substance abuse recovery and treatment centers in the southeastern coastal area of Florida, the Seastone of Delray – Drug Rehabilitation and Alcohol Treatment Center, owned and run by Ethema Health Corporation (OTCQB: GRST), is already standing out among its peers for the highly efficient individualized treatment options it offers its clients. Located in Delray Beach, which is often referred to as the rehab capital of America, Seastone offers a wide range of treatment programs of varying intensity, depending on each client’s needs. Unlike other centers, Seastone distinguishes itself by the attention paid to the individual client and family, making sure a highly detailed assessment is conducted before a specialized treatment plan is devised.

With a focus on customized treatment plans designed to help clients overcome their substance abuse issues permanently, Ethema Health Corporation’s center provides two forms of outpatient treatment: an intensive outpatient program, and a partial hospitalization program. Both approaches are built around the concepts of cognitive behavioral therapy and peer support, aiming to help clients see themselves and the world more clearly, and realize and accept that they’re facing an addiction issue, ultimately developing their stress management skills and self-esteem for long-term success.

Seastone’s drug and alcohol addiction treatment programs are divided into six stages, being structured for optimum recovery and accommodating any of their treatment plans. The six stages are:

Foundation – where clients get the highest level of direction and support to build a foundation for long-term recovery,
Discovery – where clients are taught to discard unhealthy ideas and habits gained during active addiction,
Creation – the development of sober, effective life skills,
Performance – helping clients gain more responsibility and independence,
Integration – clients continue to achieve more independence and responsibility by reintegrating in society,
Freedom – living full time in the community and dealing with real life issues.

Various treatment options and services are available for substance abuse treatment and recovery, ranging from psychiatric evaluation and drug addiction education to individual and group therapy, Eye Movement Desensitization and Reprocessing treatment, art therapy, yoga or qigong, and more. While it does not provide initial detox services, Seastone does work closely with local detox units to offer clients all the support they need and then transfer them to the facility for long-term treatment. The center’s detox programs are designed to follow and expand on the detoxification process begun in a medical setting, with the purpose of helping clients stay clean and sober for the long term. This stage of the program can begin only after the client is medically stable and free of all withdrawal symptoms.

Ethema Health Corporation’s methods are focused on getting concrete results and complete recovery from addiction, a fact also acknowledged by the Joint Commission on Accreditation of Healthcare Organizations. The worldwide organization has granted Seastone its Gold Seal of Approval®, which speaks to the professionalism and high-quality of services offered. Ethema’s unique efficiencies, together with its outstanding location, are seen as drivers of the company’s long-term operational and financial success

For more information about Ethema Health Corporation and Seastone, visit the substance abuse recovery facility online at www.seastonedrugrehab.com

Let us hear your thoughts: Ethema Health Corporation Message Board

Two recent Wall Street Journal articles reveal that labor pressures are mounting in the construction industry as hiring accelerates across the U.S. economy. The U.S. Labor Department recently reported that nonfarm payrolls rose by a seasonally adjusted 211,000 in April, and the unemployment rate fell to 4.4%, the lowest level in nearly a decade. Contractors across the country report significant shortages of electricians, carpenters, plumbers, and other skilled and semi-skilled laborers as the volume of building projects increases.

The shortage of skilled labor in many markets has forced contractors to boost pay scales, which has been a contributing factor to new home price increases over the past two years. Construction labor costs are currently rising an average of 4% to 5% annually, outpacing inflation, according to Anirban Basu, chief economist of the Associated Builders and Contractors. “The situation is going to get worse,” he said (http://dtn.fm/bm4Uu). It’s estimated that the construction industry presently needs 500,000 more skilled and semi-skilled workers, while another 600,000+ additional workers would be needed should the $1 trillion infrastructure bill proposed by the current administration be passed.

The skilled labor supply shortage isn’t expected to ease soon, as many top construction workers went to work for energy companies during the last building downturn and are now tending to oil rigs and building drilling platforms. ProBility Media Corp. (OTCQB: PBYA) is playing a major role in meeting this fast growing demand for job training and continuing education in the current economy. ProBility is one of the leading online providers of career advancement and training content for tradesmen and technical experts. By building the first full-service training and career advancement brand in the technical fields, the company is changing the landscape of the skilled trades training and certification industry.

ProBility is committed to preparing individuals with training, support, and continued education and teaches the skills needed to land and retain good jobs. The company, through strategic acquisitions, has also become one of the go-to sources for e-learning and training content, exam preparation, testing, certification, continuing education, and career advancement tools for both engineers and tradesmen. The broad collection of the company’s comprehensive educational programs is unparalleled, providing individuals and institutions with the skill sets needed to succeed. ProBility will continue to organically grow revenues from current operations while also strategically acquiring synergistic companies, thereby defragmenting and centralizing the skilled trades training marketplace.

The national unemployment rate for construction workers still remains in double digits, but economists note that figure includes both skilled and unskilled workers and finding a skilled worker not already working is increasingly rare. Finding highly specialized trade workers “is proving very, very difficult,” said James Bolger, director of operations at Colorado Concept Lighting Inc., a high-end electrical contractor that has sought for several months to double its staff of four electricians. “It’s almost like looking for a unicorn or jackalope…” (http://dtn.fm/PfZ0C).

ProBility is changing the search for skilled workers from fantasy to reality and is likely to reward investors along the way.

For more information, visit the company’s website at www.ProBilityMedia.com

Let us hear your thoughts: ProBility Media Corp. Message Board

While some investors still view the marijuana market as a new industry, the mammoth potential of the cannabis industry — both in the United States and worldwide — cannot be discounted. While marijuana has not yet been legalized in the U.S. at the federal level, 29 states as well as the District of Columbia have, so far, passed laws or initiatives to legalize or regulate it, and the industry has been growing at an unexpectedly high rate. Some savvy companies are safeguarding against the risk of violating present federal laws by capitalizing on the growth of the cannabis industry in a hands-off way, serving marijuana-related companies without touching the plant themselves. One such company is SinglePoint, Inc. (OTC: SING).

As discussed in a recent article (http://dtn.fm/msS5J), SinglePoint is building an acquisition portfolio of undervalued subsidiaries with a focus on innovative technologies. Within the marijuana industry, the company is pursuing different opportunities to build corporate value and maintain diversification. SingleSeed, SinglePoint’s marijuana vertical, is serving cannabis dispensaries that are currently hampered in their operations due to the present lack of banking options for businesses within the marijuana industry. SingleSeed is engaged in providing mobile payment processing solutions, text message marketing and business tools to marijuana dispensaries, with a long-term goal of building SingleSeed.com into a hub where dispensaries can purchase the products they need to conduct business. It is also planned that SingleSeed will offer consulting services for cannabis businesses that need assistance in getting a foothold and becoming successful in their strategies.

SinglePoint’s own strategy further involves the utilization of marijuana-related technology through its investment in Convectium, which is a successful equipment, branding and packaging solutions provider to the marijuana industry. Convectium has developed the very first cartridge and vape pen oil filling machines created for wholesale distribution to cannabis dispensaries. The 710Shark and 710Seal machines offered by Convectium, currently sold through the EquipCanna.com brand, can fill and package more than 100 cartridges or disposable vape pens in 30 seconds, revolutionizing the inefficient traditional method of hand-filling cartridges. Convectium additionally operates a consumer brand that includes HazeSticks and BlackoutX, with a customer reach that encompasses more than 52 countries.

SinglePoint recently signed a reseller agreement that enables the company to begin onboarding “high risk” merchant accounts, which includes more than 100 types of businesses. Cannabis businesses are currently counted among these high-risk business types, along with enterprises like auctions, gambling, vape pen sales, online gaming and others. Serving SinglePoint’s diversification strategy, this move will enable the company to provide payment solutions to cannabis businesses as soon as the marijuana industry becomes bankable. Offering payment solutions to various verticals in this way enlarges SinglePoint’s target market and paves the way for enormous success in catering to an underserved market.

For more information, visit the company’s website at www.SinglePoint.com

Let us hear your thoughts: SinglePoint, Inc. Message Board

China’s booming economy has delivered consumer product companies some of the world’s greatest growth opportunities over the last 20 years. However, the government recently lowered its official five-year annual GDP growth target to 6.5 percent, the slowest targeted growth since the 2008 global financial crisis. China’s economy is actually undergoing a structural transition. Consumption isn’t rising as fast as it did during peak boom years, but consumption growth is still on a staggering upward trajectory. China’s consumer economy is projected to expand by about half, to $6.5 trillion, by 2020. In fact, incremental Chinese consumer growth of over $2 trillion over the next three years would be equal to adding a consumer market larger than that of Germany today. Despite a slowing economy, China will remain one of the fastest growing consumer markets in the world for the foreseeable future.

Upward mobility and demographic forces are transforming the Chinese consumer markets. The meteoric rise of upper-middle-class households, a new generation of free spending tech savvy consumers and the powerful pull of e-commerce all promise immense new consumer opportunities.

Research by The Boston Consulting Group and AliResearch, the research arm of Alibaba, China’s largest e-commerce company (http://nnw.fm/2mt9X), found that these forces of change will profoundly reshape China’s economy and consumer market over the next several years. Consumers 35 or younger will account for 65% of growth, and e-commerce will become a far more important retail channel, driving 42% of total consumption growth, with 90% of that growth coming from mobile e-commerce. Companies will need a new playbook to capture the coming wave of growth, as the strategies of the past will no longer be relevant.

To capture the immense new opportunities in China’s changing consumer market, companies must be more strategic in targeting income segments, product categories, and retail channels. Companies also need a new set of strategies to take into account rapid shifts in the nature of consumption. Serving the businesses that feed the demand of the new Chinese consumer, Moxian, Inc. (NASDAQ: MOXC) is positioned to profit from this vast economic shift in China.

Moxian provides small- and medium-sized businesses cutting edge turnkey solutions to attract and maintain customers. The company’s strategy is to drive consumer traffic from online to their brick and mortar business customers. Moxian operates a social network platform which integrates social media and business into a single platform and offers products, features and services that appeal to consumers.

The company’s online platforms and mobile applications, the Moxian+ User app and the Moxian+ Business app, allow businesses to interface with both existing and new customers. These interactions provide each business the data to analyze consumer likes, dislikes and trends. Moxian’s platform gives businesses the ability to create, manage and promote individualized customer loyalty programs, targeted advertising campaigns and special promotions. These interactions between users and Moxian’s merchant clients give businesses the ability to study consumer behavior and tailor offerings to customers. Moxian is leveraging technology to drive business in the new Chinese consumer economy and offers an interesting opportunity to profit from this explosive growth.

For more information, visit www.Moxian.com

Substance abuse, in particular when it comes to prescription drugs, is on the rise across the United States, with an estimated 15 million Americans being addicted to prescription medicine – more than the total number of heroin, cocaine, and hallucinogens users combined. Known as a spring-break destination and a state of heavy drinking, with about 58 percent of people being regular drinkers, Florida also has a serious substance abuse problem, with almost 3,000 drug-induced deaths reported in the state on an annual basis. Organizations such as Ethema Health Corporation (OTCQB: GRST) are working hard to tackle the negative effects of addiction on the local population by offering some of the most innovative and comprehensive substance abuse treatments available across the state.

According to statistics from DrugRehab.com, almost half of people addicted to heroin and opioids in Florida are aged 30 and under, while more than 3,000 of the patients admitted to rehabilitation in 2015 statewide were under 18 years of age (roughly 10.6 percent of the total number of people who sought treatment for their addiction problem). In addition, Florida prescribes up to 10 times more oxycodone than all the other states combined and has one of the highest rates of overdose deaths in the country, according to the Addiction Blog (http://dtn.fm/PF6mi).

The startling figures explain why Florida is also a known center for rehabilitation facilities. Often referred to as the rehab capital of America, Delray Beach is home to multiple addiction centers, including Ethema Health Corporation’s Seastone Drug Rehabilitation and Alcohol Treatment Center. Opened in 2012, the facility’s comprehensive, holistic approach to substance abuse treatment and recovery has quickly positioned it as a leader in a highly competitive market, as well as a center focused on getting long-lasting results and the complete recovery of its clients.

The company’s unique approach revolves around the concept of treating not only the addiction but also any underlying disorders that enabled the substance abuse in the first place. Additionally, the center focuses on providing only highly customized and individualized treatment options, designed to ensure that each and every client gets a treatment plan tailored to their specific needs and problems.

Multiple treatment programs are available at the facility, ranging from drug addiction education and psychiatric evaluation to individual and group therapy, eye movement desensitization and reprocessing, yoga and art therapy, and more. All the treatments are results oriented and focused on the concept of inclusion, which means that throughout their rehabilitation process all clients receive core team support in the form of family or friends. The treatment plans available at the facility are designed to aid clients throughout their entire journey to recovery, from understanding and accepting their addiction problem to developing the necessary skills to live their lives after leaving rehab.

Ethema’s client-focused, non-judgmental approach is making the company a major provider of quality addiction treatment services in Florida. The company’s professionalism has also been acknowledged by the Joint Commission on Accreditation of Healthcare Organizations, which has granted Seastone its Gold Seal of Approval®.

For more information about Ethema Health Corporation and Seastone, visit www.seastonedrugrehab.com

Let us hear your thoughts: Ethema Health Corporation Message Board

ChineseInvestors.com, Inc. (OTCQB: CIIX) is projected to reach revenues of $14.8 million by fiscal year 2020, according to a new research report by Consilium Global Research (http://dtn.fm/d849H). Per the report, the company did $930,000 in revenue for fiscal 2016 and is projected to grow at a compound annual growth rate (CAGR) of approximately 100% through 2020. The underlying market’s CAGR will expand at an 80% rate, the report said. Consilium sees CIIX as going through a huge transformation this year as it pursues a larger stake in the cannabis market.

Headquartered in San Gabriel, California, CIIX offers a range of consulting services and educational tools for Chinese investors, but, most recently, it has been pursuing a presence in the growing cannabidiol (CBD) market. In line with these efforts, the company opened the first online CBD store in the Chinese language in the free trade area of Shanghai. It seeks to serve some 1.4 billion people. The site will sell hemp-based food and beverages and hemp-derived CBD. It seeks to sell, where legal, to Chinese-speaking consumers worldwide through its online store, www.ChineseCBDoil.com.

Consilium, an independent research company, notes in its report that the CBD industry is anticipated to grow to $2.1 billion by 2020, representing a CAGR of 80%. The research firm goes on to forecast that the sales of $14.8 million by FY2020 predicted for CIIX is achievable due to the company management’s ability to execute. In fact, Consilium feels that its projections could easily prove conservative. It also estimated that CIIX could reach sales of $1.86 million in FY2017, $3.7 million in FY2018 and $7.4 million in FY2019. CIIX reported revenues of $930,000 in FY2016. For the nine months ended February 28, 2017, it reported revenues of $1.35 million.

Consilium believes that CIIX has a strong management team that has entrepreneurial skills and vision. It also finds that the firm is engrained with Chinese speakers in both the U.S. and abroad. Weaknesses are that it may have to raise more money to compete. It will also need to have sufficient and appropriate resources to stay abreast of evolving requirements for legality in the U.S. and abroad, per the research report.

With no impediments cited by the report in terms of brand leaders, laws, or standouts in this nascent market, Consilium sees opportunities for growth for CIIX. These include strategic international expansion, the large size of the Chinese market and the successful leverage of the legal cannabis market, which Consilium anticipates will drive growth for years to come.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

The Job Openings and Labor Turnover Summary (JOLTS) released on Tuesday May 9, 2017, by the Bureau of Labor Statistics (BLS) shows that ProBility Media Corp. (OTCQB: PBYA) has got its ducks lined up in a row. The JOLTS proclaimed happy tidings: the number of manufacturing jobs added in March was the highest for any month since ‘the front end of the Great Recession in early 2008’, according to U.S. News (http://dtn.fm/ORz1Z). But this good news was bundled with some bad news. America is experiencing a skills gap: a mismatch between the skills employers require and the skills the workforce possesses. ProBility Media Corp., however, is aiming to narrow that gap. With its suite of technical training and testing solutions, the company is empowering America’s craftsmen and skilled workers once again.

The JOLTS report (http://dtn.fm/vM5mu) revealed that, in March, manufacturing industries added 322,000 to their payrolls. This brings to 922,000 the number of manufacturing hires for the first quarter of 2017, an 11 percent year-over-year increase on 2016. The report also showed that there were 394,000 job openings at the end of March, matching the record highest, attained in July 2016, since April 2006. Manufacturing output has expanded substantially since the doldrums of the financial crisis in 2009, with the St. Louis Fed’s index of real manufacturing output recording a rise of 29 percent. Contrary to widespread reports, manufacturing employment has also risen since the Great Depression, although less than output. FRED (Federal Reserve Economic Data) shows employment in the sector rising by 8 percent, from 11,475,000 in December 2009 to 12,396,000 in April 2017 (http://dtn.fm/3XnsM).

While the data provides some reassurance that American manufacturing is alive and well, it also reveals a disturbing trend of layoffs, which signals a skills gap. In March, some 105,000 manufacturing workers were laid off. Factories are hiring, but they’re firing, too.

However, ProBility is endeavoring to fill that skills gap. The company provides a range of education and training programs for a wide variety of vocational occupations such as craning, rigging, electrical, plumbing and HVAC.

ProBility is disrupting the technical vocations training and certification industry by creating the first full service training and career advancement brand in the technical fields. It has undertaken a major push into the crane training space and is now developing online training programs employing virtual reality technology. ProBility’s crane e-learning products include full crane operator’s courses that simulate the hands-on experience of a lab and physical school. In addition, its publishing division has been working to create full handbooks to accompany the online courses.

ProBility continues to expand its suite of e-learning, training and testing services, through both acquisitions and internal growth. The company is positioning itself as the go-to resource for individuals, small- and medium-size businesses, and large enterprise customers by offering consistent high-quality training services and materials for education, testing, and career advancement.

For more information, visit the company’s website at www.ProBilityMedia.com

Let us hear your thoughts: ProBility Media Corp. Message Board